Qube Research & Technologies (QRT)’s CVS Health CVS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Sell	144,900 -35,600	-20%	-$3.18M	0.01%	1053
2026 Q1	$13M	Sell	180,500 -73,900	-29%	-$5.69M	0.01%	1126
2025 Q4	$20.2M	Buy	254,400 +83,600	+49%	+$6.59M	0.02%	906
2025 Q3	$12.9M	Sell	170,800 -153,700	-47%	-$10.5M	0.01%	1163
2025 Q2	$22.4M	Sell	324,500 -86,800	-21%	-$5.69M	0.02%	815
2025 Q1	$27.9M	Buy	411,300 +261,100	+174%	+$15.6M	0.03%	603
2024 Q4	$6.74M	Buy	150,200 +121,900	+431%	+$6.84M	0.01%	1328
2024 Q3	$1.78M	Sell	28,300 -2,400	-8%	-$140K	﹤0.01%	1801
2024 Q2	$1.81M	Buy	30,700 +26,100	+567%	+$1.63M	﹤0.01%	1683
2024 Q1	$367K	Buy	+4,600	New	+$351K	﹤0.01%	2706

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CVS Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its CVS Health (CVS) stake by 47% in Q2 2026, selling an estimated $89.5M and leaving 1,147,850 shares worth $119M. The position accounts for 0.11% of the portfolio, ranked #235.

Qube Research & Technologies (QRT) first reported a position in CVS in Q1 2018 and has held it in 26 quarters since. The position peaked at $154M in Q1 2026. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Qube Research & Technologies (QRT) held 1,147,850 shares of CVS Health worth $119M as of Q2 2026.
Qube Research & Technologies (QRT) sold 1,002,516 CVS Health shares in Q2 2026, an estimated $89.5M.
CVS Health made up 0.11% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #235 holding.
Qube Research & Technologies (QRT) first reported a position in CVS Health in Q1 2018 and has held it in 26 quarters since.
Qube Research & Technologies (QRT)'s CVS Health position peaked at $154M in Q1 2026.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.